Total and functional antibody response to a quadrivalent meningococcal polysaccharide vaccine among children

Journal of Pediatrics

Volumn 128, Issue 2, 1996, Pages 196-202

  King, W J ^a   MacDonald, N E ^a   Wells, G ^a   Huang, J ^a   Allen, U ^a   Chan, F ^a   Ferris, W ^a   Diaz Mitoma, F ^a   Ashton, F ^a  

^a CHILDREN S HOSPITAL OF EASTERN ONTARIO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; BACTERIUM ANTIBODY; MENINGOCOCCUS VACCINE;

ADOLESCENT; ADULT; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; CHILD; ENZYME LINKED IMMUNOSORBENT ASSAY; FEVER; HUMAN; INFANT; MAJOR CLINICAL STUDY; MENINGOCOCCOSIS; NEISSERIA MENINGITIDIS; PRIORITY JOURNAL; RASH; SUBCUTANEOUS DRUG ADMINISTRATION; VACCINATION;

EID: 0030022159     PISSN: 00223476     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-3476(96)70389-X     Document Type: Article

References (35)

1. LA Jackson A Schuchat MW Reeves JD. Wenger Serogroup C meningococcal outbreaks in the United States JAMA 273 1995 383 389
2. CM Whalen JC Hockin A Ryan F. Ashton The changing epidemiology of invasive meningococcal disease in Canada, 1985 through 1992 JAMA 273 1995 390 394
3. C. Gray Meningococcal disease: was Ottawa mass-vaccination program necessary? Can Med Assoc J 146 1992 1033 1037
4. SE. Hume Mass voluntary immunization campaigns for meningococcal disease in Canada: media hysteria JAMA 267 1992 1833 1838
5. JD Wenger LA Jackson P Raj MJ. Tonelli Issues in the control of outbreaks of group C meningococcal disease in the United States Infect Dis Clin Pract 3 1994 136 140
6. I Goldschneider EC Gotschlich MS. Artenstein Human immunity to the meningococcus. I. The role of humoral antibodies J Exp Med 129 1969 1307 1326
7. I Goldschneider EC Gotschlich MS. Artenstein Human immunity to the meningococcus. II. Development of natural immunity J Exp Med 129 1969 1327 1348
8. EC Gotschlich I Goldschneider MS. Artenstein Human immunity to the meningococcus. IV. Immunogenicity of group A and C meningococcal polysaccharides in humans volunteers J Exp Med 129 1969 1367 1384
9. R Gold M Lepow I Goldschneider Clinical evaluation of group A and group C meningococcal polysaccharide vaccines in infants J Clin Invest 56 1975 1536 1547
10. R Gold M. Artenstein Meningococcal infections: field trial of group C meningococcal polysaccharide vaccine in 1969-70 Bull World Health Organ 45 1971 279 282
11. V Amato-Neto H Finger I Goldschneider Serologic response to serogroup C meningococcal vaccine in Brazilian pre-school children Rev Inst Med Trop Sao Paulo 16 1974 149 157
12. A Taunay PA Galvas JA de Morais Disease prevention by meningococcal group C polysaccharide vaccine in pre-school children [Abstract] Pediatr Res 8 1974 429A
13. H Peltola A Safary U Karanko Evaluation of two tetravalent (A,C,Y,W-135) meningococcal vaccines in infants and children. A clinical study comparing immunogenicity of O-acetyl negative and O-acetyl positive group C polysaccharides Pediatrics 76 1985 91 95
14. R Gold ML Lepow I Goldschneider Kinetics of antibody production to group A and group C meningococcal polysaccharide vaccines administered during the first six years of life: prospects for routine immunization in infants and children J Infect Dis 140 1979 690 697
15. R Gold ML Lepow I Goldschneider EC Gotschlich Immune response of human infants to polysaccharide vaccines of groups A and C Neisseria meningitidis J Infect Dis 136 1977 s31 s35
16. M Lepow I Goldschneider R Gold M Randolph E. Gotschlich Persistence of antibody following immunization of children with group A and group C meningococcal polysaccharides Pediatrics 60 1977 673 679
17. AS Monto BL Brandt MS Artenstein Response of children to Neisseria meningitidis polysaccharide vaccines J Infect Dis 127 1973 394 400
18. I Goldschneider ML Lepow EC Gotschlich Immunogenicity of group A and group C meningococcal polysaccharides in human infants J Infect Dis 128 1973 769 776
19. I Goldschneider M Lepow E. Gotschlich Immunogenicity of the group A and group C meningococcal polysaccharides in human infants J Infect Dis 125 1972 509 559
20. I. Gemmil An outbreak of meningococcal disease in Ottawa-Carleton December 1991-February 1992 Can J Public Health 83 1992 134 137
21. JA Morello WM Janda GV Doern Neisseria and Branhamella 5th ed A Balows WJ Hausler KJ Hermann HD Isenberg HJ Shadomy Manual of clinical microbiology 1991 : American Society for Microbiology Washington, DC 258 276
22. GM Carlone CE Frasch GR Siber Multicenter comparison of levels of antibody to the Neisseria meningitidis group A polysaccharide measured by using an enzyme-linked immunosorbent assay J Clin Microbiol 30 1992 154 159
23. G Arakere CE. Frasch Specificity of antibodies to 0-acetyl-positive and o-acetyl-negative group C meningococcal polysaccharides in sera from vaccinee and carriers Infect Immun 59 1991 4349 4356
24. PK Holder SE Maslanka LB Pais J Dykes BD Plikaytis GM Carlone Assignment of Neisseria meningitidis serogroup A and C class-specific anticapsular antibody concentrations to the new standard references serum CDC1992 Clinical and Diagnostic Laboratory Immunology 2 1995 132 137
25. CE Frasch SS Chapman Classification of Neisseria meningitidis group B into distinct serotypes Infect Immun 5 1972 98 102
26. Special Family Income Tabulations 1990. Small Area and Administrative Data Division, Statistics Canada.
27. Statistics Canada Profile of census tracts in Ottawa-Hull, Part A Ottawa. Industry, Science and Technology Canada 1992 1991 Census of Canada. Catalog No 95-350
28. M Lepow J Beeler M Randolph Reactogenicity and immunogenicity of a quadravalent combined meningococcal polysaccharide vaccine in children J Infect Dis 154 1986 1033 1036
29. H. Peltola Meningococcal disease: still with us Rev Infect Dis 5 1983 71 90
30. N LeSaux F Ashton M Rahman Carriage of Neisseria species in communities with different rates of meningococcal disease Can J Infect Dis 3 1992 60 64
31. R Gold I Goldschneider ML Lepow Carriage of Neisseria meningitidis and Neisseria lactamica in infants and children J Infect Dis 137 1978 112 121
32. EC. Gotschlich Development of polysaccharide vaccines for the prevention of meningococcal disease Monogr Allergy 9 1975 245 258
33. H Peltola PH Makela H Kayhty Clinical efficacy of meningococcus group A capsular polysaccharide vaccine in children three months to five years of age N Engl J Med 297 1977 686 691
34. Meningococcal vaccine. National Advisory Committee on Immunization Canadian immunization guide 4th ed 1993 : Minister of Supply and Services Ottawa, Canada 78 81
35. Guidelines for control of meningococcal disease Canada Communicable Disease Report 20-3 1994 17 27